Browsing by Author GEMO Study Collaborators
Showing results 1 to 11 of 11
| Issue Date | Title | Author(s) |
|---|---|---|
| 17-Feb-2021 | A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | Pujana Genestar, M. Ángel; Teulé-Vega, Àlex; GEMO Study Collaborators; EMBRACE Collaborators; KConFab Investigators; HEBON Investigators; ABCTB Investigators |
| 25-Apr-2015 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers | Teulé-Vega, Àlex; Lázaro García, Conxi; Blanco Guillermo, Ignacio; Valle Domínguez, Jesús del; COGS (Collaborative Oncological Gene-environment Study); CIMBA Consortium; EMBRACE Collaborators; HEBON Investigators; GEMO Study Collaborators; CONSIT Team (CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella, Italy) |
| 28-Jul-2021 | Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores | Barnes, Daniel R.; Angel Pujana, Miquel; Teulé Vega, Àlex; Balmaña, Judith; GEMO Study Collaborators; EMBRACE Collaborators; KConFab Investigators; HEBON Investigators; Consortium Of Investigators Of Modifiers Of Brca1 And Brca2, The; Brunet, Joan; Darder, Esther; Valle Domínguez, Jesús del; Diez, Orland; Feliubadaló i Elorza, Maria Lídia; Izquierdo, Angel; Lazaro, Conxi; López Fernández, Adrià |
| Apr-2016 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 | Pujana Genestar, M. Ángel; EMBRACE Collaborators; GEMO Study Collaborators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) |
| 1-Feb-2017 | Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers | Lázaro García, Conxi; BCFR Investigators; EMBRACE Collaborators; GEMO Study Collaborators; HEBON Investigators; KConFab Investigators |
| 15-Apr-2019 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer | Lázaro García, Conxi; GC-HBOC Study Collaborators; GEMO Study Collaborators; EMBRACE Collaborators; HEBON Investigators; BCFR Investigators; ABCTB Investigators |
| 1-Jun-2020 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses | Zhan, Haoyu; Ahearn, Thomas U.; Lecarpentier, Julie; Lázaro García, Conxi; EMBRACE Collaborators; GEMO Study Collaborators |
| 27-Mar-2013 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Blanco Guillermo, Ignacio; Australian Cancer Study; Australian Ovarian Cancer Study Group; GENICA (Gene Environment Interaction and Breast Cancer); SWE-BRCA Group; HEBON Investigators; EMBRACE Collaborators; GEMO Study Collaborators |
| 1-Oct-2020 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants | Brunet, Joan; Izquierdo i Font, Àngel Xavier; Lázaro García, Conxi; Pujana Genestar, M. Ángel; GEMO Study Collaborators; EMBRACE Collaborators; KConFab Investigators; HEBON Investigators; GENEPSO Investigators |
| 1-Nov-2019 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer | Figlioli, Gisella; Lázaro García, Conxi; Pujana Genestar, M. Ángel; ABCTB Investigators; GEMO Study Collaborators; KConFab Investigators |
| 1-Mar-2020 | Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status | Feng, Helian; Gusev, Alexander; Pasaniuc, Bogdan; Lázaro García, Conxi; Teulé-Vega, Àlex; GEMO Study Collaborators; EMBRACE Collaborators; GC‐HBOC Study Collaborators; ABCTB Investigators; HEBON Investigators; BCFR Investigators; OCGN Investigators |